|
| |||||||||||||||||||||||||||||||||
Background The safety of administering the combined measlesmumpsrubella (MMR) vaccine to patients who are allergic to eggs has been debated for decades because of concern about potential anaphylaxis, since the live attenuated virus used in the vaccine is grown in cultured chick-embryo fibroblasts.
Methods We recruited 54 children (mean age, 18.5 months) who had not previously been vaccinated and were allergic to eggs. The children's histories of allergy were confirmed with skin tests and double-blind, placebo-controlled food-challenge tests; some children also underwent skin testing with the MMR vaccine. We then routinely administered the vaccine to the children in one subcutaneous (0.5-ml) dose.
Results All 54 children had positive results on skin testing with egg. Allergy to eggs was confirmed in 26 of the children by convincing histories of anaphylaxis after the ingestion of eggs, in 22 children by food-challenge tests, and in 6 patients by convincing histories of recent allergic reactions occurring after the ingestion of eggs. Of the 17 children who underwent skin testing with the MMR vaccine, 3 had positive results. All 54 children received the MMR vaccine as a single subcutaneous injection; none had an immediate or delayed adverse reaction.
Conclusions The MMR vaccine can be safely administered in a single dose to children with allergy to eggs, even those with severe hypersensitivity.
Source Information
From the Department of Pediatrics, Divisions of Pediatric Allergy and Immunology, and the Center for Applied Research and Evaluation, Arkansas Children's Hospital Research Institute and the University of Arkansas for Medical Sciences, Little Rock (J.M.J., A.W.B., P.K.R.); and the Department of Pediatrics and the Division of Immunology and Allergy, Johns Hopkins University School of Medicine, Baltimore (H.A.S.).
Address reprint requests to Dr. James at the Arkansas Children's Hospital, 800 Marshall St., Little Rock, AR 72202.
This article has been cited by other articles:
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved. |